Trials / Completed
CompletedNCT02501863
Analgesic Effect of Ropivacaine Plus Fentanyl vs Ropivacaine for Continuous 3-in-1 FNB After Total Knee Arthroplasty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- National Medical Center, Seoul · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The postoperative analgesic effect of the continuous 3-in-1 femoral nerve block (FNB) with ropivacaine/fentanyl or with ropivacaine were compared in total knee arthroplasty.
Detailed description
Forty patients of American Society of Anesthesiologist physical status Ⅰor Ⅱ undergoing total knee arthroplasty under spinal anesthesia would be enrolled and randomly divided into two groups (R, "3-in-1" using a 30 ml of ropivacaine 0.375% and a continuous 3-in-1 with a ropivacaine 0.2%(8mL/h) for 48 h after operation, RF: Fifty ug of fentanyl will be added to a bolus(30ml ropivacaine 0.375%) and 1ug/ml of fentanyl will be mixed to a continuous infusion(8mg/h, ropivacaine 0.2%). Spinal anesthesia will be done after the insertion of femoral catheter. IV PCA with hydromorphone(0.15mg/ml, 0-1-10), will be used for rescue analgesics. Visual analgesia scale, hydromorphone consumption, side effects until 48h after operation and satisfaction will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Femoral nerve block with ropivacaine+fentanyl | Ropivacaine+fentanyl are used for continuous femoral nerve block, spinal anesthesia, IV-PCA with hydromorphone |
| DRUG | Femoral nerve block with ropivacaine | Ropivacaine is used for continuous femoral nerve block, spinal anesthesia, IV-PCA with hydromorphone |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-07-01
- Completion
- 2016-08-01
- First posted
- 2015-07-17
- Last updated
- 2016-09-14
Source: ClinicalTrials.gov record NCT02501863. Inclusion in this directory is not an endorsement.